EpiBone, Inc. Receives FDA Clearance to Commence its First-In-Human, Phase 1/2 Trial of its Bone Product, EB-CMF

General Press Releases Thursday May 23, 2019 08:15
NEW YORK--23 May--PRNewswire/InfoQuest
  • Potential breakthrough technology for stem-cell based bone replacement

EpiBone, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) clearance to proceed with a Phase 1/2 clinical trial of its lead bone product EpiBone-Craniomaxillofacial (EB-CMF), as a potential treatment for ramus continuity defects in the mandible. The ramus is a key component of the jaw bone which attaches to the muscles associated with chewing.

EB-CMF is a living anatomically correct bone graft manufactured from a patient's own adipose derived stem cells. This eliminates the need to harvest bone from a patient's body, potentially reducing pain, surgical and hospitalization time while creating a precision fit with the defect.

"We are proud of the work that has been put into this IND, and are grateful to our entire team, as well as all our investors, consultants, and champions in the field who have made this possible," commented Dr. Nina Tandon, CEO and Co-Founder of EpiBone. "Our technology has the potential to change the field of skeletal reconstruction as we know it. Our goal is to help as many patients as we can to regain optimal form and function, in the most seamless, long-term, and natural way possible."

The Phase 1/2 clinical study will evaluate the EB-CMF product directly in patients with mandibular ramus continuity defects which require reconstruction. In addition to the primary safety of EB-CMF, the study is also designed to demonstrate the effectiveness of EB-CMF in bone reconstruction in addition to integration with the native tissue. The company expects to enroll 6 patients in this study. The company hopes this study will inform the exploration of other potential indications for other facial reconstructive surgeries requiring bone grafts, as well as studies for cartilage replacement in the knee, and other areas of the body.

About EpiBone

EpiBone, Inc. is privately-held regenerative medicine company focused on skeletal reconstruction. Sitting at the intersection of biology and engineering, the company harnesses the power of a patient's own cells to create living solutions that become a seamless part of a patient's body. EpiBone is currently developing a pipeline of bone, cartilage, and compound (bone and cartilage) products.

For more information, please visit: https://www.epibone.com/
Disclaimer

This communication contains forward-looking statements which can generally can be identified by words such as "plans," "change," "will," "following", "strengthening," "developing, the negative of these words and similar words and expressions, which are based on EpiBone's current expectations, assumptions, estimates and projections about its business, technology, product development and industry. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and include, without limitation, EpiBone's ability to (1) adequately protect or enforce its intellectual property rights, (2) develop and commercialize new products and technologies on a timely basis (or at all), (3) risks associated with acquisitions and strategic investments and (4) attract and retain qualified personnel. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. Additionally, this communication does not constitute an offer to sell or a solicitation of an offer to buy securities.

Logo - https://mma.prnewswire.com/media/890744/EpiBone_Logo.jpg

Latest Press Release

Come 4, Pay 3 seafood buffet promotion at Aloft Bangkok Sukhumvit 11

Calling seafood lovers! Crave Wine Bar & Restaurant, Aloft Bangkok – Sukhumvit 11 presents its new Seafood Fri-Sat Dinner Buffet Promotion to all diners to enjoy at a worthy price! Savor the freshest seafood, such as oysters, blue crab, rock...

Metro On Wireless Restaurant Lays Out the Royal Treatment for Mothers Day

Metro On Wireless Restaurant at Hotel Indigo Bangkok Wireless Road wants to treat every mom like a queen with a fantastic feast full of delicious choices. So, on Monday, 12 August 2019, Metro On Wireless is serving up an all-you-can-eat a la carte buffet...

Taste of Traditional Italian Cheese at Giorgios

Giorgio's at Royal Orchid Sheraton Hotel & Towers takes great pride in characteristic Italian cheese to create special dishes with uncompromising quality ingredients, rich flavors and culinary creativity. Starting with an irresistible bites of cheese...

Discover Thailands northern delights at Thara Thong

Thara Thong proudly presents "Regional Thai Food Festival" – The Art of Four Regions of Thailand Cuisine throughout 2019. From July to August, Thailand's northern region dishes originated from the ancient Kingdom of Lanna, which make Northern Thai...

Hotel Indigo Bangkok Wireless Road wins Best Boutique City Hotel Worldwide from the Hotel of The Year Awards 2019

Hotel Indigo Bangkok Wireless Road is proud to be an award-winner on the Top 100 Luxury Hotels Worldwide by the Hotel of the Year Awards 2019 with recognition as a Best Boutique City Hotel Worldwide!. The Hotel of the Year Awards recognize and reward...

Related Topics